Take the Peptide Quiz to see if MOTS-c fits your goals, or explore the MOTS-c peptide profile for a complete overview of mechanism, benefits, and biology
In: Drugs and Lactation Database (LactMed) [Internet]
Retatrutide Pen Specifications VLS Retatrutide 20mg Pre-filled Injection Pen Retatrutide Research Benefits Triple receptor action Targets GLP-1, GIP, and glucagon receptors for comprehensive metabolic research Appetite regulation Researched for its effects on hunger signalling and satiety Metabolic health Shows promise in studies related to glucose control and insulin sensitivity Weight management Investigated for potential effects on body composition Convenient format Pre-filled pen with precise, easy administration How Retatrutide Works Retatrutide is a novel triple agonist peptide that activates three key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor
Comparative Risk: In patients with Type 2 Diabetes, GLP-1 RA use was associated with a 7% lower cancer incidence compared with DPP4 inhibitors
In addition, it is particularly effective for individuals without diabetes, with some experiencing over 20% weight loss within 6 months
Large employer plans are most likely to cover Wegovy with prior authorization